2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
ABCD PBi
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Autor:
Mach, F.
;
Baigent, C.
;
Catapano, A. L.
;
Koskinas, K. C.
;
Casula, M.
;
Badimon, L.
;
Chapman, M. J.
;
De Backer, G. G.
;
Delgado, V.
;
Ference, B. A.
;
Graham, I. M.
;
Halliday, A.
;
Landmesser, U.
;
Mihaylova, B.
;
Pedersen, T. R.
;
Riccardi, G.
;
Richter, D. J.
;
Sabatine, M. S.
;
Taskinen, M. R.
;
Tokgozoglu, L.
;
Wiklund, Olov
;
Mueller, C.
;
Drexel, H.
;
Aboyans, V.
;
Corsini, A.
;
Doehner, W.
;
Farnier, M.
;
Gigante, B.
;
Kayikcioglu, M.
;
Krstacic, G.
;
Lambrinou, E.
;
Lewis, B. S.
;
Masip, J.
;
Moulin, P.
;
Petersen, S.
;
Petronio, A. S.
;
Piepoli, M. F.
;
Pinto, X.
;
Raber, L.
;
Ray, K. K.
;
Reiner, Z.
;
Riesen, W. F.
;
Roffi, M.
;
Schmid, J. P.
;
Shlyakhto, E.
;
Simpson, I. A.
;
Stroes, E.
;
Sudano, I.
;
Tselepis, A. D.
;
Viigimaa, M.
;
Vindis, C.
;
Vonbank, A.
;
Vrablik, M.
;
Vrsalovic, M.
;
Gomez, J. L. Z.
;
Collet, J. P.
Assuntos:
all-cause
;
apolipoprotein B
;
c-reactive
;
Cardiac
and
Cardiovascular
Systems
;
Cardiovascular
System & Cardiology
;
cholesterol
;
chronic kidney-disease
;
coronary-heart-disease
;
density-lipoprotein cholesterol
;
dyslipidaemias
;
familial hypercholesterolaemia
;
Guidelines
;
high-density lipoproteins
;
high-dose atorvastatin
;
homozygous familial hypercholesterolemia
;
intima-media thickness
;
Kardiologi
;
lipoprotein remnants
;
lipoprotein(a)
;
lipoproteins
;
low-density
;
low-density lipoproteins
;
mortality
;
patients
;
protein
;
statin-treated
;
total
cardiovascular
risk
;
treatment (adherence)
;
treatment (drugs)
;
treatment (lifestyle)
;
triglycerides
;
type-2 diabetes-mellitus
;
very
É parte de:
European heart journal, 2020, Vol.41 (1), p.111
Idioma:
Inglês